after evaluation of the clinical efficacy and the tolerance of lymecycline 2 x 300 mg/day in patients with subacute sinusitis , we may conclude that lymecycline can be considered a first choice antibioticum in the treatment of acute and subacute sinusitis ( tetralysal ) .
C0024200
lymecycline
C1260648
tetralysal